Innovotech Inc.

Equities

IOT

CA45772U1049

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 01:07:14 08/05/2024 am IST			5-day change	1st Jan Change
0.12 ^CAD	+20.00%		0.00%	+60.00%

25/04	Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Innovotech Inc. Announces CFO Changes	CI

Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 24, 2023 at 03:14 am IST

Innovotech Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was CAD 0.255692 million compared to CAD 0.276648 million a year ago. Net loss was CAD 0.083005 million compared to CAD 0.032287 million a year ago.

Latest news about Innovotech Inc.

Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Innovotech Inc. Announces CFO Changes	12/12	CI
Innovotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11	CI
Innovotech Inc. acquired 60% stake in Nou Life Sciences Inc..	25/23/25	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	16/23/16	CI
Innovotech Inc. Appoints Julie Wright to Its Board of Directors	17/23/17	CI
Innovotech Inc. Announces CEO Changes	17/23/17	CI
Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Innovosil -1 Antimicrobial Silver Works Against Candida Auris and Superbugs	16/23/16	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25	CI
Innovotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	16/22/16	CI
Innovotech Inc. Announces Retirement of Gerard Tertzakian as Director	26/22/26	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	17/22/17	CI
Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
Innovotech Inc. Announces Termination of Collaboration Agreement for Innovosil-1 Antimicrobial Silver	21/22/21	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	25/21/25	CI
Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	26/21/26	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	20/21/20	CI
Innovotech Inc Announces Management Changes	15/21/15	CI
Innovotech Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	12/20/12	CI
Innovotech Inc. announced that it has received CAD 0.375 million in funding	02/20/02	CI
Innovotech Inc. announced that it expects to receive CAD 0.375 million in funding	24/20/24	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/20/12	CI
Innovotech Signs Collaboration Agreement for InnovoSIL-1	15/20/15	CI

Chart Innovotech Inc.

Duration

Period

More charts

Company Profile

Innovotech Inc. is a Canada-based biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.

Sector

Biotechnology & Medical Research

Calendar

21/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
INNOVOTECH INC.	+60.00%	3.44M
MODERNA, INC.	+33.04%	50.85B
IQVIA HOLDINGS INC.	+0.31%	42.82B
LONZA GROUP AG	+49.62%	42.03B
CELLTRION, INC.	-4.96%	29.55B
ICON PUBLIC LIMITED COMPANY	+10.73%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-22.15%	19.13B
BIO-TECHNE CORPORATION	+8.64%	13.05B
MEDPACE HOLDINGS, INC.	+27.07%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.43%	12.08B

Other Biotechnology & Medical Research